Division of Molecular Biology and Genetics, Istanbul University, Institute of Graduate Studies in Sciences, Istanbul, Turkey.
Division of Immunology and Allergic Diseases, Department of Internal Medicine, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey.
J Asthma. 2022 Apr;59(4):663-672. doi: 10.1080/02770903.2020.1870129. Epub 2021 Jan 8.
There is evidence that reactive oxygen species, especially free radicals, produced during the immune and inflammatory response may play important roles in the development of asthma.We aimed to evaluate the levels of certain oxidative stress biomarkers and antioxidant capacity in asthma patients with different asthma control levels in comparison to healthy subjects.
A total of 120 adult allergic asthma patients and 120 healthy individuals were included in this study. Using spectrophotometric methods, we analyzed two oxidative stress markers, levels of malondialdehyde (MDA) and protein carbonyls (PC), as well as reduced glutathione (GSH), total antioxidant capacity (FRAP) and catalase activity as critical antioxidant defense parameters in the blood samples of allergic asthma patients and healthy controls. The patients were divided into 3 subgroups according to asthma control test (ACT) results: totally controlled (TCG), partially controlled (PCG) and uncontrolled (UCG) subgroups. All biomarkers were compared between the three patient subgroups, as well as between total asthma patients and control subjects.
There were remarkable differences between the control group and the combined patient group for all parameters. A significant increase in MDA and PC, especially in the UCG ( < 0.01 and < 0.05, respectively) was detected in comparison to other subgroups. Additionally, increased MDA and PC levels, as well as decreased GSH levels were observed in all subgroups individually in comparison to the control ( < 0.001).
This research demonstrates the presence of severe oxidative stress, considering the increase in lipid peroxidation and protein oxidation, in patients with allergic asthma, even under controlled conditions.
有证据表明,免疫和炎症反应过程中产生的活性氧物质(尤其是自由基)可能在哮喘的发展中发挥重要作用。我们旨在评估不同哮喘控制水平的哮喘患者与健康受试者相比,某些氧化应激生物标志物和抗氧化能力的水平。
本研究共纳入 120 例成年过敏性哮喘患者和 120 例健康个体。我们使用分光光度法分析了两种氧化应激标志物,即丙二醛(MDA)和蛋白羰基(PC)的水平,以及还原型谷胱甘肽(GSH)、总抗氧化能力(FRAP)和过氧化氢酶活性作为血液中过敏性哮喘患者和健康对照的关键抗氧化防御参数。根据哮喘控制测试(ACT)结果,将患者分为 3 个亚组:完全控制(TCG)、部分控制(PCG)和未控制(UCG)亚组。比较了三个患者亚组之间以及所有哮喘患者与对照组之间的所有生物标志物。
与对照组相比,所有参数在患者组中均有显著差异。与其他亚组相比,UCG 组的 MDA 和 PC 显著增加(分别为 <0.01 和 <0.05)。此外,与对照组相比,所有亚组的 MDA 和 PC 水平升高,GSH 水平降低(均 <0.001)。
即使在控制条件下,本研究表明过敏性哮喘患者存在严重的氧化应激,这是由于脂质过氧化和蛋白质氧化增加所致。